Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

Table 4

Chi-squared test of organ rejection.

	Yes	No	Total
Group 2	4	5	9	1.000	0.000
Group 3	20	24	44
Total	24	29	53
Group 1	3	10	13	0.148	2.088
Group 3	20	24	44
Total	23	34	57
Group 1	3	10	13	0.376	—
Group 2	4	5	9
Total	7	15	22